OC90

Chr 8

otoconin 90

Also known as: PLA2L

Predicted to enable calcium ion binding activity; calcium-dependent phospholipase A2 activity; and phospholipid binding activity. Predicted to be involved in otolith mineralization; phosphatidylcholine metabolic process; and phosphatidylglycerol metabolic process. Predicted to be located in extracellular region. Predicted to be active in extracellular matrix. [provided by Alliance of Genome Resources, Jul 2025]

OMIMResearchGenerating clinical summary…
LOEUF 1.27
Clinical SummaryOC90
Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint?
1.27LOEUF
pLI 0.000
Z-score 0.57
OE 0.87 (0.601.27)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint?
-1.01Z-score
OE missense 1.18 (1.071.30)
301 obs / 255.5 exp
Tolerant

Tolerant to missense variation

Observed / Expected Ratios?
LoF OE?0.87 (0.601.27)
00.351.4
Missense OE?1.18 (1.071.30)
00.61.4
Synonymous OE?1.28
01.21.6
LoF obs/exp: 19 / 21.9Missense obs/exp: 301 / 255.5Syn Z: -2.15

ClinVar Variant Classifications

0 submitted variants in ClinVar

Protein Context — Lollipop Plot

OC90 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →